CHIEF COMMERCIAL OFFICER · Harmony Biosciences Holdings, Inc. · Common Stock
Side
M
Value
—
Shares
7,500
Price
—
Executed
Apr 7, 2026
Disclosed
Apr 9, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 7 executedApr 9, 2026 disclosed
HRMY · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Zaeske Adam H. filed this Form 4 reporting a option exercise of HRMY on Apr 7, 2026. It became public on Apr 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF COMMERCIAL OFFICER
Zaeske Adam H.cik:0002064712
Issuer
Harmony Biosciences Holdings, Inc.cik:0001802665
Revision history · 0
No field has changed since this record was first ingested.
